Next in Health
A weekly healthcare podcast series hosted by PwC's Health Industries that addresses industry trends and timely health policy topics impacting patients, providers, payers, pharmaceutical and life sciences companies as well as vendors and new entrants.
Next in Health
Key strategies for global pharma companies to reduce risk and drive growth in the China market
Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:
- Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese market
- Three approaches organizations can consider to competing at a local level in China
- Impacts to different functions across the value chain such as R&D, supply chain, and IT
Speakers:
Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC
Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC
Igor Belokrinitsky, Strategy& Principal, PwC
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.